127 related articles for article (PubMed ID: 26643040)
1. Screening for early breast cancer reduces invasive cancer, study finds.
Mayor S
BMJ; 2015 Dec; 351():h6576. PubMed ID: 26643040
[No Abstract] [Full Text] [Related]
2. DCIS and invasive interval breast cancer.
Foucar E
Lancet Oncol; 2016 Mar; 17(3):e87. PubMed ID: 26972860
[No Abstract] [Full Text] [Related]
3. DCIS and invasive interval breast cancer.
Narod SA; Sopik V; Sun P
Lancet Oncol; 2016 Mar; 17(3):e87-e88. PubMed ID: 26972859
[No Abstract] [Full Text] [Related]
4. DCIS and invasive interval breast cancer - Author's reply.
Duffy SW
Lancet Oncol; 2016 Mar; 17(3):e88-e89. PubMed ID: 26972861
[No Abstract] [Full Text] [Related]
5. Detection of DCIS and reduced invasive interval cancers.
Evans A
Lancet Oncol; 2016 Jan; 17(1):14-5. PubMed ID: 26655426
[No Abstract] [Full Text] [Related]
6. Detection of ductal carcinoma in situ and subsequent interval cancers.
Shieh Y; Eklund M; Esserman L
BMJ; 2016 Feb; 352():i551. PubMed ID: 26834245
[No Abstract] [Full Text] [Related]
7. StatBite: Percent change in DCIS, invasive breast cancer, and mammography.
J Natl Cancer Inst; 2011 Mar; 103(6):457. PubMed ID: 21393608
[No Abstract] [Full Text] [Related]
8. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
Barratt A
BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
[No Abstract] [Full Text] [Related]
9. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
10. Echogenicity of breast cancer: is it of prognostic value?
Soon PS; Vallentine J; Palmer A; Magarey CJ; Schwartz P; Morris DL
Breast; 2004 Jun; 13(3):194-9. PubMed ID: 15177421
[TBL] [Abstract][Full Text] [Related]
11. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
12. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
[TBL] [Abstract][Full Text] [Related]
13. Active Surveillance for Ductal Carcinoma in Situ: Shining Light Into the Modeling Abyss.
Etzioni R; Gulati R
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26683406
[No Abstract] [Full Text] [Related]
14. Persistent Untreated Screening-Detected Breast Cancer: An Argument Against Delaying Screening or Increasing the Interval Between Screenings.
Arleo EK; Monticciolo DL; Monsees B; McGinty G; Sickles EA
J Am Coll Radiol; 2017 Jul; 14(7):863-867. PubMed ID: 28457814
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
16. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
17. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
[TBL] [Abstract][Full Text] [Related]
18. Is mammographic breast density a breast cancer risk factor in women with BRCA mutations?
Passaperuma K; Warner E; Hill KA; Gunasekara A; Yaffe MJ
J Clin Oncol; 2010 Aug; 28(23):3779-83. PubMed ID: 20625126
[TBL] [Abstract][Full Text] [Related]
19. Stable incidence of advanced breast cancer argues against screening effectiveness.
Autier P; Pizot C; Boniol M
BMJ; 2014 Nov; 349():g6358. PubMed ID: 25424316
[No Abstract] [Full Text] [Related]
20. Mammography screening study hampered by inadequate data.
Tabár L
BMJ; 2014 Nov; 349():g6823. PubMed ID: 25424720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
